Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply

Aliment Pharmacol Ther. 2020 Jun;51(12):1442-1443. doi: 10.1111/apt.15769. Epub 2020 May 14.

Abstract

LINKED CONTENT

This article is linked to King et al and Benson‐Pope and Greary papers. To view these articles, visit https://doi.org/10.1111/apt.15701 and https://doi.org/10.1111/apt.15759.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Inflammatory Bowel Diseases*
  • Pandemics*
  • Pneumonia, Viral
  • Prevalence
  • SARS-CoV-2